Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea (Page 2 - References)

EGCG is the most studied and is considered to play a crucial role in cancer-preventive and therapeutic activities

For the main article: 
Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea

References (to the main article)

[1]

B.A. Kohler, R.L. Sherman, N. Howlader, A. Jemal, A.B. Ryerson, K.A. Henry, et al.Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state

J Natl Cancer Inst, 107 (2015), p. djv048

Google Scholar

[2]

I. Rady, I.A. Siddiqui, M. Rady, H. MukhtarMelittin, a major peptide component of bee venom, and its conjugates in cancer therapy

Cancer Lett, 402 (2017), pp. 16-31

ArticleDownload PDFView Record in ScopusGoogle Scholar

[3]

H. Frankish15 million new cancer cases per year by 2020, says WHO

Lancet, 361 (2003), p. 1278

ArticleDownload PDFView Record in ScopusGoogle Scholar

[4]

J. Zugazagoitia, C. Guedes, S. Ponce, I. Ferrer, S. Molina-Pinelo, L. Paz-AresCurrent challenges in cancer treatment

Clin Ther, 38 (2016), pp. 1551-1566

ArticleDownload PDFView Record in ScopusGoogle Scholar

[5]

L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, A. JemalGlobal cancer statistics

CA Cancer J Clin, 65 (2015) (2012), pp. 87-108

View Record in ScopusGoogle Scholar

[6]

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Int J Cancer, 136 (2015), pp. E359-386

CrossRefView Record in ScopusGoogle Scholar

[7]

R.L. Siegel, K.D. Miller, A. JemalCancer statistics

CA Cancer J Clin, 66 (2016) (2016), pp. 7-30

CrossRefView Record in ScopusGoogle Scholar

[8]

S.Z. Moghadamtousi, M. Fadaeinasab, S. Nikzad, G. Mohan, H.M. Ali, H.A. KadirAnnona muricata (Annonaceae): a review of its traditional uses, isolated acetogenins and biological activities

Int J Mol Sci, 16 (2015), pp. 15625-15658

CrossRefView Record in ScopusGoogle Scholar

[9]

B. Peter, S. Bosze, R. HorvathBiophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials

Eur Biophys J, 46 (2017), pp. 1-24

CrossRefGoogle Scholar

[10]

U.P. de Albuquerque, G.T. Soldati, S.S. Sieber, M.A. Ramos, J.C. de Sa, L.C. de SouzaThe use of plants in the medical system of the Fulni-o people (NE Brazil): a perspective on age and gender

J Ethnopharmacol, 133 (2011), pp. 866-873

ArticleDownload PDFView Record in ScopusGoogle Scholar

[11]

E.E. Camargo, M.A. Bandeira, A.G. de OliveiraDiagnosis of public programs focused on herbal medicines in Brazil

Nat Prod Commun, 6 (2011), pp. 1001-1002

Google Scholar

[12]

G. Komlaga, C. Agyare, R.A. Dickson, M.L. Mensah, K. Annan, P.M. Loiseau, et al.Medicinal plants and finished marketed herbal products used in the treatment of malaria in the Ashanti region, Ghana

J Ethnopharmacol, 172 (2015), pp. 333-346

ArticleDownload PDFView Record in ScopusGoogle Scholar

[13]

I.A. Siddiqui, V.M. Adhami, N. Ahmad, H. MukhtarNanochemoprevention: sustained release of bioactive food components for cancer prevention

Nutr Cancer, 62 (2010), pp. 883-890

CrossRefView Record in ScopusGoogle Scholar

[14]

S.M. Chacko, P.T. Thambi, R. Kuttan, I. NishigakiBeneficial effects of green tea: a literature review

Chin Med, 5 (2010), p. 13

CrossRefGoogle Scholar

[15]

J.A. VinsonBlack and green tea and heart disease: a review

Biofactors, 13 (2000), pp. 127-132

CrossRefView Record in ScopusGoogle Scholar

[16]

C. Snoussi, R. Ducroc, M.H. Hamdaoui, K. Dhaouadi, H. Abaidi, F. Cluzeaud, et al.Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet

J Nutr Biochem, 25 (2014), pp. 557-564

ArticleDownload PDFView Record in ScopusGoogle Scholar

[17]

M. Sano, M. Tabata, M. Suzuki, M. Degawa, T. Miyase, M. Maeda-YamamotoSimultaneous determination of twelve tea catechins by high-performance liquid chromatography with electrochemical detection

Analyst, 126 (2001), pp. 816-820

View Record in ScopusGoogle Scholar

[18]

J. Steinmann, J. Buer, T. Pietschmann, E. SteinmannAnti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea

Br J Pharmacol, 168 (2013), pp. 1059-1073

CrossRefView Record in ScopusGoogle Scholar

[19]

C.S. Yang, H. WangCancer therapy combination: green tea and a phosphodiesterase 5 inhibitor?

J Clin Invest, 123 (2013), pp. 556-558

CrossRefView Record in ScopusGoogle Scholar

[20]

H.H. Bailey, H. MukhtarGreen tea polyphenols and cancer chemoprevention of genitourinary cancer

Am Soc Clin Oncol Educ Book (2013), pp. 92-96

CrossRefView Record in ScopusGoogle Scholar

[21]

N. Khan, H. MukhtarCancer and metastasis: prevention and treatment by green tea

Cancer Metastasis Rev, 29 (2010), pp. 435-445

CrossRefView Record in ScopusGoogle Scholar

[22]

I.A. Siddiqui, V. SannaImpact of nanotechnology on the delivery of natural products for cancer prevention and therapy

Mol Nutr Food Res, 60 (2016), pp. 1330-1341

CrossRefView Record in ScopusGoogle Scholar

[23]

M. Saleem, V.M. Adhami, I.A. Siddiqui, H. MukhtarTea beverage in chemoprevention of prostate cancer: a mini-review

Nutr Cancer, 47 (2003), pp. 13-23

CrossRefView Record in ScopusGoogle Scholar

[24]

D.G. Nagle, D. Ferreira, Y.D. ZhouEpigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives

Phytochemistry, 67 (2006), pp. 1849-1855

ArticleDownload PDFView Record in ScopusGoogle Scholar

[25]

V.M. Adhami, N. Ahmad, H. MukhtarMolecular targets for green tea in prostate cancer prevention

J Nutr, 133 (2003), pp. 2417S-2424S

Google Scholar

[26]

I.A. Siddiqui, V.M. Adhami, D.J. Bharali, B.B. Hafeez, M. Asim, S.I. Khwaja, et al.Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate

Cancer Res, 69 (2009), pp. 1712-1716

View Record in ScopusGoogle Scholar

[27]

H. Wagner, G. Ulrich-MerzenichSynergy research: approaching a new generation of phytopharmaceuticals

Phytomedicine, 16 (2009), pp. 97-110

ArticleDownload PDFView Record in ScopusGoogle Scholar

[28]

S.N. Saldanha, T.O. TollefsbolThe role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes

J Oncol, 2012 (2012), p. 192464

Google Scholar

[29]

R.Y. Gan, H.B. Li, Z.Q. Sui, H. CorkeAbsorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review

Crit Rev Food Sci Nutr (2016), pp. 1-18

CrossRefView Record in ScopusGoogle Scholar

[30]

A.A. Rahman, S. Makpol, R. Jamal, R. Harun, N. Mokhtar, W.Z. NgahTocotrienol-rich fraction, [6]-gingerol and epigallocatechin gallate inhibit proliferation and induce apoptosis of glioma cancer cells

Molecules, 19 (2014), pp. 14528-14541

CrossRefView Record in ScopusGoogle Scholar

[31]

T.J. Somers-Edgar, M.J. Scandlyn, E.C. Stuart, M.J. Le Nedelec, S.P. Valentine, R.J. RosengrenThe combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo

Int J Cancer, 122 (2008), pp. 1966-1971

View Record in ScopusGoogle Scholar

[32]

F. Ye, G.H. Zhang, B.X. Guan, X.C. XuSuppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin

World J Gastroenterol, 18 (2012), pp. 126-135

CrossRefView Record in ScopusGoogle Scholar

[33]

P. Wang, D. Heber, S.M. HenningQuercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells

Nutr Cancer, 64 (2012), pp. 580-587

CrossRefView Record in ScopusGoogle Scholar

[34]

S. Nair, A. Barve, T.O. Khor, G.X. Shen, W. Lin, J.Y. Chan, et al.Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells

Acta Pharmacol Sin, 31 (2010), pp. 1223-1240

CrossRefView Record in ScopusGoogle Scholar

[35]

G.J. Du, C.Z. Wang, L.W. Qi, Z.Y. Zhang, T. Calway, T.C. He, et al.The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells

Phytother Res, 27 (2013), pp. 272-277

CrossRefView Record in ScopusGoogle Scholar

[36]

S.F. Kostin, D.E. McDonald, D.W. McFaddenInhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro

J Surg Res, 177 (2012), pp. 255-262

ArticleDownload PDFView Record in ScopusGoogle Scholar

[37]

S. Toden, H.M. Tran, O.A. Tovar-Camargo, Y. Okugawa, A. GoelEpigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer

Oncotarget, 7 (2016), pp. 16158-16171

View Record in ScopusGoogle Scholar

[38]

H. Wu, Y. Xin, C. Xu, Y. XiaoCapecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts

Exp Ther Med, 3 (2012), pp. 650-654

CrossRefView Record in ScopusGoogle Scholar

[39]

S.H. Lee, H.J. Nam, H.J. Kang, H.W. Kwon, Y.C. LimEpigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway

Eur J Cancer, 49 (2013), pp. 3210-3218

ArticleDownload PDFView Record in ScopusGoogle Scholar

[40]

H. Wu, Y. Xin, Y. Xiao, J. ZhaoLow-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts

Cancer Biother Radiopharm, 27 (2012), pp. 204-209

CrossRefView Record in ScopusGoogle Scholar

[41]

M.E. Stearns, M.D. Amatangelo, D. Varma, C. Sell, S.M. GoodyearCombination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice

Am J Pathol, 177 (2010), pp. 3169-3179

ArticleDownload PDFCrossRefView Record in ScopusGoogle Scholar

[42]

Y. Zhang, S.X. Wang, J.W. Ma, H.Y. Li, J.C. Ye, S.M. Xie, et al.EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition

J Neurooncol, 121 (2015), pp. 41-52

CrossRefView Record in ScopusGoogle Scholar

[43]

S.N. Saldanha, R. Kala, T.O. TollefsbolMolecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate

Exp Cell Res, 324 (2014), pp. 40-53

ArticleDownload PDFView Record in ScopusGoogle Scholar

[44]

M.W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki, M. RathAnti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145

Res Commun Mol Pathol Pharmacol, 115–116 (2004), pp. 251-264

View Record in ScopusGoogle Scholar

[45]

D.H. Zhou, X. Wang, M. Yang, X. Shi, W. Huang, Q. FengCombination of low concentration of (-)-epigallocatechin gallate (EGCG) and curcumin strongly suppresses the growth of non-small cell lung cancer in vitro and in vivo through causing cell cycle arrest

Int J Mol Sci, 14 (2013), pp. 12023-12036

CrossRefView Record in ScopusGoogle Scholar

[46]

A. Papi, F. Farabegoli, R. Iori, M. Orlandi, G.R. De Nicola, M. Bagatta, et al.Vitexin-2-O-xyloside, raphasatin and (-)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells

Food Chem, 138 (2013), pp. 1521-1530

ArticleDownload PDFView Record in ScopusGoogle Scholar

[47]

R.M. Hagen, V.S. Chedea, C.P. Mintoff, E. Bowler, H.R. Morse, M.R. LadomeryEpigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells

Int J Oncol, 43 (2013), pp. 194-200

CrossRefView Record in ScopusGoogle Scholar

[48]

S. Shankar, G. Suthakar, R.K. SrivastavaEpigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer

Front Biosci, 12 (2007), pp. 5039-5051

CrossRefView Record in ScopusGoogle Scholar

[49]

V. Sanna, C.K. Singh, R. Jashari, V.M. Adhami, J.C. Chamcheu, I. Rady, et al.Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy

Sci Rep, 7 (2017), p. 41573

Google Scholar

[50]

S.W. Tait, D.R. GreenMitochondria and cell death: outer membrane permeabilization and beyond

Nat Rev Mol Cell Biol, 11 (2010), pp. 621-632

CrossRefView Record in ScopusGoogle Scholar

[51]

J.F. Kerr, A.H. Wyllie, A.R. CurrieApoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics

Br J Cancer, 26 (1972), pp. 239-257

CrossRefView Record in ScopusGoogle Scholar

[52]

R.C. Taylor, S.P. Cullen, S.J. MartinApoptosis: controlled demolition at the cellular level

Nat Rev Mol Cell Biol, 9 (2008), pp. 231-241

CrossRefView Record in ScopusGoogle Scholar

[53]

M.L. Xu, J. Hu, B.P. Guo, Y.R. Niu, C. Xiao, Y.X. XuExploration of intrinsic and extrinsic apoptotic pathways in zearalenone-treated rat sertoli cells

Environ Toxicol (2015)

Google Scholar

[54]

A. Chalah, R. Khosravi-FarThe mitochondrial death pathway

Adv Exp Med Biol, 615 (2008), pp. 25-45

CrossRefView Record in ScopusGoogle Scholar

[55]

C. Langlais, M.A. Hughes, K. Cain, M. MacFarlaneIn vitro assembly and analysis of the apoptosome complex

Cold Spring Harb Protoc, 2015 (2015)

pdb.prot087080

Google Scholar

[56]

M. Brentnall, L. Rodriguez-Menocal, R.L. De Guevara, E. Cepero, L.H. BoiseCaspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis

BMC Cell Biol, 14 (2013), p. 32

CrossRefGoogle Scholar

[57]

D. Siegmund, D. Mauri, N. Peters, P. Juo, M. Thome, M. Reichwein, et al.Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway

J Biol Chem, 276 (2001), pp. 32585-32590

View Record in ScopusGoogle Scholar

[58]

E. KavanaghQuantification of active caspase-3 and active caspase-8 in microglia cells

Methods Mol Biol, 1041 (2013), pp. 113-120

CrossRefView Record in ScopusGoogle Scholar

[59]

L.L. Pan, A.Y. Wang, Y.Q. Huang, Y. Luo, M. LingMangiferin induces apoptosis by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal carcinoma cell line

Asian Pac J Cancer Prev, 15 (2014), pp. 7065-7068

CrossRefView Record in ScopusGoogle Scholar

[60]

W. Xu, L. Jing, Q. Wang, C.C. Lin, X. Chen, J. Diao, et al.Bax-PGAM5L-Drp1 complex is required for intrinsic apoptosis execution

Oncotarget, 6 (2015), pp. 30017-30034

View Record in ScopusGoogle Scholar

[61]

K.T. Chang, A. Anishkin, G.A. Patwardhan, L.J. Beverly, L.J. Siskind, M. ColombiniCeramide channels: destabilization by Bcl-xL and role in apoptosis

Biochim Biophys Acta, 2015 (1848), pp. 2374-2384

Google Scholar

[62]

C. DeOcesano-Pereira, M.S. Amaral, K.S. Parreira, A.C. Ayupe, J.F. Jacysyn, G.P. Amarante-Mendes, et al.Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis

Nucleic Acids Res, 42 (2014), pp. 8343-8355

CrossRefView Record in ScopusGoogle Scholar

[63]

S.Y. Yu, R. QiRole of bad in podocyte apoptosis induced by puromycin aminonucleoside

Transplant Proc, 45 (2013), pp. 569-573

ArticleDownload PDFView Record in ScopusGoogle Scholar

[64]

S. Ma, C. Hockings, K. Anwari, T. Kratina, S. Fennell, M. Lazarou, et al.Assembly of the Bak apoptotic pore: a critical role for the Bak protein alpha6 helix in the multimerization of homodimers during apoptosis

J Biol Chem, 288 (2013), pp. 26027-26038

CrossRefView Record in ScopusGoogle Scholar

[65]

C. Gao, W.J. Guo, A.Y. WangSignificance of decreased apoptosis, role of Bid expression and Bcl-Xl/Bid ratio in human jejunal stromal tumors

APMIS, 120 (2012), pp. 171-181

CrossRefView Record in ScopusGoogle Scholar

[66]

N. Muthalagu, M.R. Junttila, K.E. Wiese, E. Wolf, J. Morton, B. Bauer, et al.BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues

Cell Rep, 8 (2014), pp. 1347-1353

ArticleDownload PDFView Record in ScopusGoogle Scholar

[67]

C. Chen, L. Qincao, J. Xu, S. Du, E. Huang, C. Liu, et al.Role of PUMA in methamphetamine-induced neuronal apoptosis

Toxicol Lett, 240 (2016), pp. 149-160

ArticleDownload PDFView Record in ScopusGoogle Scholar

[68]

S. Mukhopadhyay, P.K. Panda, N. Sinha, D.N. Das, S.K. BhutiaAutophagy and apoptosis: where do they meet?

Apoptosis, 19 (2014), pp. 555-566

CrossRefView Record in ScopusGoogle Scholar

[69]

H. He, L.H. Zang, Y.S. Feng, L.X. Chen, N. Kang, S. Tashiro, et al.Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-kappaB survival pathway in A375–S2 cells

J Ethnopharmacol, 148 (2013), pp. 544-555

ArticleDownload PDFView Record in ScopusGoogle Scholar

[70]

Y. Zhang, Y. Hao, Q. Sun, C. PengRole of Smac in apoptosis of lung cancer cells A549 induced by Taxol

Clin Lab, 61 (2015), pp. 17-21

CrossRefView Record in ScopusGoogle Scholar

[71]

E.R. Hahm, J. Lee, S.V. SinghRole of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells

Mol Carcinog, 53 (2014), pp. 907-916

CrossRefView Record in ScopusGoogle Scholar

[72]

A.R. SafaC-FLIP, a master anti-apoptotic regulator

Exp Oncol, 34 (2012), pp. 176-184

View Record in ScopusGoogle Scholar

[73]

Y. Tang, D.Y. Zhao, S. Elliott, W. Zhao, T.J. Curiel, B.S. Beckman, et al.Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression

Int J Oncol, 31 (2007), pp. 705-711

View Record in ScopusGoogle Scholar

[74]

A. Basu, S. HaldarCombinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death

Int J Oncol, 34 (2009), pp. 281-286

View Record in ScopusGoogle Scholar

[75]

R.L. Thangapazham, N. Passi, R.K. MaheshwariGreen tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells

Cancer Biol Ther, 6 (2007), pp. 1938-1943

CrossRefView Record in ScopusGoogle Scholar

[76]

P.P. Wu, S.C. Kuo, W.W. Huang, J.S. Yang, K.C. Lai, H.J. Chen, et al.(-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway

Anticancer Res, 29 (2009), pp. 1435-1442

CrossRefView Record in ScopusGoogle Scholar

[77]

Q. Hu, X. Chang, R. Yan, C. Rong, C. Yang, S. Cheng, et al.(-)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein

Med Oncol, 32 (2015), p. 390

CrossRefGoogle Scholar

[78]

C. Onoda, K. Kuribayashi, S. Nirasawa, N. Tsuji, M. Tanaka, D. Kobayashi, et al.(-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression

Int J Oncol, 38 (2011), pp. 1403-1408

View Record in ScopusGoogle Scholar

[79]

K.R. Landis-Piwowar, C.D. Huo, D. Chen, V. Milacic, G.Q. Shi, T.H. Chan, et al.A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent

Cancer Research, 67 (2007), pp. 4303-4310

CrossRefView Record in ScopusGoogle Scholar

[80]

M.A. Feitelson, A. Arzumanyan, R.J. Kulathinal, S.W. Blain, R.F. Holcombe, J. Mahajna, et al.Sustained proliferation in cancer: Mechanisms and novel therapeutic targets

Semin Cancer Biol, 35 (Suppl) (2015), pp. S25-54

View Record in ScopusGoogle Scholar

[81]

S. Lim, P. KaldisCdks, cyclins and CKIs: roles beyond cell cycle regulation

Development, 140 (2013), pp. 3079-3093

CrossRefView Record in ScopusGoogle Scholar

[82]

A. Suzuki, M. Hayashida, T. Ito, H. Kawano, T. Nakano, M. Miura, et al.Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation

Oncogene, 19 (2000), pp. 3225-3234

CrossRefView Record in ScopusGoogle Scholar

[83]

S. Di Agostino, S. Strano, V. Emiliozzi, V. Zerbini, M. Mottolese, A. Sacchi, et al.Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation

Cancer Cell, 10 (2006), pp. 191-202

ArticleDownload PDFView Record in ScopusGoogle Scholar

[84]

C.H. Huang, S.J. Tsai, Y.J. Wang, M.H. Pan, J.Y. Kao, T.D. WayEGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells

Mol Nutr Food Res, 53 (2009), pp. 1156-1165

CrossRefView Record in ScopusGoogle Scholar

[85]

C. Sharma, A. Nusri Qel, S. Begum, E. Javed, T.A. Rizvi, A. Hussain(-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells

Asian Pac J Cancer Prev, 13 (2012), pp. 4815-4822

View Record in ScopusGoogle Scholar

[86]

Y.C. Ma, C. Li, F. Gao, Y. Xu, Z.B. Jiang, J.X. Liu, et al.Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway

Oncol Rep, 31 (2014), pp. 1343-1349

CrossRefView Record in ScopusGoogle Scholar

[87]

S. Gupta, N. Ahmad, A.L. Nieminen, H. MukhtarGrowth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells

Toxicol Appl Pharmacol, 164 (2000), pp. 82-90

ArticleDownload PDFView Record in ScopusGoogle Scholar

[88]

Y. Qiao, J. Cao, L. Xie, X. ShiCell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells

Arch Pharm Res, 32 (2009), pp. 1309-1315

CrossRefView Record in ScopusGoogle Scholar

[89]

X. Zhang, K.W. Min, J. Wimalasena, S.J. BaekCyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate

J Cancer Res Clin Oncol, 138 (2012), pp. 2051-2060

CrossRefView Record in ScopusGoogle Scholar

[90]

N. Ahmad, V.M. Adhami, S. Gupta, P. Cheng, H. MukhtarRole of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate

Arch Biochem Biophys, 398 (2002), pp. 125-131

ArticleDownload PDFView Record in ScopusGoogle Scholar

[91]

N. Bhatia, C. Agarwal, R. AgarwalDifferential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells

Nutr Cancer, 39 (2001), pp. 292-299

CrossRefView Record in ScopusGoogle Scholar

[92]

J. FolkmanAngiogenesis

Annu Rev Med, 57 (2006), pp. 1-18

CrossRefView Record in ScopusGoogle Scholar

[93]

P. Carmeliet, R.K. JainAngiogenesis in cancer and other diseases

Nature, 407 (2000), pp. 249-257

View Record in ScopusGoogle Scholar

[94]

A. Birbrair, T. Zhang, Z.M. Wang, M.L. Messi, J.D. Olson, A. Mintz, et al.Type-2 pericytes participate in normal and tumoral angiogenesis

Am J Physiol Cell Physiol, 307 (2014), pp. C25-38

CrossRefView Record in ScopusGoogle Scholar

[95]

S. Liekens, E. De Clercq, J. NeytsAngiogenesis: regulators and clinical applications

Biochem Pharmacol, 61 (2001), pp. 253-270

ArticleDownload PDFView Record in ScopusGoogle Scholar

[96]

S.Y. Proskuryakov, V.L. GabaiMechanisms of tumor cell necrosis

Curr Pharm Des, 16 (2010), pp. 56-68

CrossRefView Record in ScopusGoogle Scholar

[97]

G. Bredholt, M. Mannelqvist, I.M. Stefansson, E. Birkeland, T.H. Bo, A.M. Oyan, et al.Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses

Oncotarget, 6 (2015), pp. 39676-39691

View Record in ScopusGoogle Scholar

[98]

K. Stieler, U. Schumacher, A.K. Horst, N. FischerXMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?

PLoS One, 7 (2012), p. e42321

CrossRefGoogle Scholar

[99]

T. Matsuoka, M. YashiroRho/ROCK signaling in motility and metastasis of gastric cancer

World J Gastroenterol, 20 (2014), pp. 13756-13766

CrossRefView Record in ScopusGoogle Scholar

[100]

H. Zhou, B. Zhang, J. Zheng, M. Yu, T. Zhou, K. Zhao, et al.The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration

Biomaterials, 35 (2014), pp. 1597-1607

ArticleDownload PDFView Record in ScopusGoogle Scholar

[101]

J. Relat, A. Blancafort, G. Oliveras, S. Cufi, D. Haro, P.F. Marrero, et al.Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer

BMC Cancer, 12 (2012), p. 280

Google Scholar

[102]

Y. Sakamoto, N. Terashita, T. Muraguchi, T. Fukusato, S. KubotaEffects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis

Biosci Biotechnol Biochem, 77 (2013), pp. 1799-1803

CrossRefView Record in ScopusGoogle Scholar

[103]

X. Li, Y. Feng, J. Liu, X. Feng, K. Zhou, X. TangEpigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1alpha and VEGF expression

J Nutrigenet Nutrigenomics, 6 (2013), pp. 169-178

ArticleDownload PDFCrossRefView Record in ScopusGoogle Scholar

[104]

L. He, E. Zhang, J. Shi, X. Li, K. Zhou, Q. Zhang, et al.(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1alpha

Cancer Chemother Pharmacol, 71 (2013), pp. 713-725

CrossRefView Record in ScopusGoogle Scholar

[105]

J. Shi, F. Liu, W. Zhang, X. Liu, B. Lin, X. TangEpigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells

Oncol Rep, 33 (2015), pp. 2972-2980

CrossRefView Record in ScopusGoogle Scholar

[106]

A. Takahashi, T. Watanabe, A. Mondal, K. Suzuki, M. Kurusu-Kanno, Z. Li, et al.Mechanism-based inhibition of cancer metastasis with (-)-epigallocatechin gallate

Biochem Biophys Res Commun, 443 (2014), pp. 1-6

ArticleDownload PDFView Record in ScopusGoogle Scholar

[107]

Z. Yin, E.C. Henry, T.A. Gasiewicz(-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor

Biochemistry, 48 (2009), pp. 336-345

CrossRefView Record in ScopusGoogle Scholar

[108]

K. Belguise, S. Guo, G.E. SonensheinActivation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells

Cancer Res, 67 (2007), pp. 5763-5770

CrossRefView Record in ScopusGoogle Scholar

[109]

Y. Zhang, G. Han, B. Fan, Y. Zhou, X. Zhou, L. Wei, et al.Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity

Eur J Pharmacol, 606 (2009), pp. 172-179

ArticleDownload PDFView Record in ScopusGoogle Scholar

[110]

T. Sen, A. ChatterjeeEpigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor alpha5beta1 in the process

Eur J Nutr, 50 (2011), pp. 465-478

CrossRefView Record in ScopusGoogle Scholar

[111]

P.N. Chen, S.C. Chu, W.H. Kuo, M.Y. Chou, J.K. Lin, Y.S. HsiehEpigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells

J Agric Food Chem, 59 (2011), pp. 3836-3844

CrossRefView Record in ScopusGoogle Scholar

[112]

Y.W. Koh, E.C. Choi, S.U. Kang, H.S. Hwang, M.H. Lee, J. Pyun, et al.Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met

J Nutr Biochem, 22 (2011), pp. 1074-1083

ArticleDownload PDFView Record in ScopusGoogle Scholar

[113]

Y.S. Hwang, K.K. Park, W.Y. ChungEpigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma

Eur J Pharmacol, 715 (2013), pp. 286-295

ArticleDownload PDFView Record in ScopusGoogle Scholar

[114]

B.H. Zhu, H.Y. Chen, W.H. Zhan, C.Y. Wang, S.R. Cai, Z. Wang, et al.(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer

World J Gastroenterol, 17 (2011), pp. 2315-2325

CrossRefView Record in ScopusGoogle Scholar

[115]

B.H. Zhu, W.H. Zhan, Z.R. Li, Z. Wang, Y.L. He, J.S. Peng, et al.(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis

World J Gastroenterol, 13 (2007), pp. 1162-1169

CrossRefView Record in ScopusGoogle Scholar

[116]

M. Shimizu, Y. Shirakami, H. Sakai, Y. Yasuda, M. Kubota, S. Adachi, et al.(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells

Chem Biol Interact, 185 (2010), pp. 247-252

ArticleDownload PDFView Record in ScopusGoogle Scholar

[117]

F. Zhou, H. Zhou, T. Wang, Y. Mu, B. Wu, D.L. Guo, et al.Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro

Acta Pharmacol Sin, 33 (2012), pp. 120-126

CrossRefView Record in ScopusGoogle Scholar

[118]

T. Maruyama, S. Murata, K. Nakayama, N. Sano, K. Ogawa, T. Nowatari, et al.(-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer

Oncol Rep, 31 (2014), pp. 625-633

CrossRefView Record in ScopusGoogle Scholar

[119]

C.A. Larsen, R.H. Dashwood(-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells

Arch Biochem Biophys, 501 (2010), pp. 52-57

ArticleDownload PDFView Record in ScopusGoogle Scholar

[120]

C.A. Larsen, R.H. DashwoodSuppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxide

Biochem Biophys Res Commun, 389 (2009), pp. 527-530

ArticleDownload PDFView Record in ScopusGoogle Scholar

[121]

J. Qin, Y. Wang, Y. Bai, K. Yang, Q. Mao, Y. Lin, et al.Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-kappaBmediated matrix metalloproteinase-9 expression

Mol Med Rep, 6 (2012), pp. 1040-1044

CrossRefView Record in ScopusGoogle Scholar

[122]

D. Duhon, R.L. Bigelow, D.T. Coleman, J.J. Steffan, C. Yu, W. Langston, et al.The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells

Mol Carcinog, 49 (2010), pp. 739-749

View Record in ScopusGoogle Scholar

[123]

S.C. Lee, W.K. Chan, T.W. Lee, W.H. Lam, X. Wang, T.H. Chan, et al.Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo

Nutr Cancer, 60 (2008), pp. 483-491

CrossRefView Record in ScopusGoogle Scholar

[124]

M.A. Moses, E.C. Henry, W.A. Ricke, T.A. GasiewiczThe heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model

Cancer Prev Res (Phila), 8 (2015), pp. 249-257

CrossRefView Record in ScopusGoogle Scholar

[125]

S. Wang, R. Chen, Z. Zhong, Z. Shi, M. Chen, Y. WangEpigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells

Am J Chin Med, 42 (2014), pp. 1279-1300

View Record in ScopusGoogle Scholar

[126]

J.D. Lambert, S. Sang, C.S. YangN-Acetylcysteine enhances the lung cancer inhibitory effect of epigallocatechin-3-gallate and forms a new adduct

Free Radic Biol Med, 44 (2008), pp. 1069-1074

ArticleDownload PDFView Record in ScopusGoogle Scholar

[127]

S. Gupta, K. Hastak, N. Ahmad, J.S. Lewin, H. MukhtarInhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

Proc Natl Acad Sci U S A, 98 (2001), pp. 10350-10355

View Record in ScopusGoogle Scholar

[128]

L. D'Angelo, G. Piazzi, A. Pacilli, A. Prossomariti, C. Fazio, L. Montanaro, et al.A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells

Carcinogenesis, 35 (2014), pp. 2314-2320

CrossRefView Record in ScopusGoogle Scholar

[129]

A. Kale, S. Gawande, S. Kotwal, S. Netke, W. Roomi, V. Ivanov, et al.Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract

Phytother Res, 24 (Suppl 1) (2010), pp. S48-55

CrossRefView Record in ScopusGoogle Scholar

[130]

S. Dawood, L. Austin, M. CristofanilliCancer stem cells: implications for cancer therapy

Oncology, 28 (2014), pp. 1101-1107

[1110]

View Record in ScopusGoogle Scholar

[131]

J.A. Ajani, S. Song, H.S. Hochster, I.B. SteinbergCancer stem cells: the promise and the potential

Semin Oncol, 42 (Suppl 1) (2015), pp. S3-17

View Record in ScopusGoogle Scholar

[132]

S.N. Tang, C. Singh, D. Nall, D. Meeker, S. Shankar, R.K. SrivastavaThe dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

J Mol Signal, 5 (2010), p. 14

CrossRefGoogle Scholar

[133]

N.D. Mineva, K.E. Paulson, S.P. Naber, A.S. Yee, G.E. SonensheinEpigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells

PLoS One, 8 (2013), p. e73464

CrossRefGoogle Scholar

[134]

N. Nishimura, T.B. Hartomo, T.V. Pham, M.J. Lee, T. Yamamoto, S. Morikawa, et al., Y. Takeshima, K. Iijima, M. Matsuo, H. NishioEpigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells

Environ Health Prev Med, 17 (2012), pp. 246-251

CrossRefView Record in ScopusGoogle Scholar

[135]

D.W. Eom, J.H. Lee, Y.J. Kim, G.S. Hwang, S.N. Kim, J.H. Kwak, et al.Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells

BMB Rep, 48 (2015), pp. 461-466

View Record in ScopusGoogle Scholar

[136]

D.Z. Wei, J.Y. Yang, J.W. Liu, W.Y. TongInhibition of liver cancer cell proliferation and migration by a combination of (-)-epigallocatechin-3-gallate and ascorbic acid

J Chemother, 15 (2003), pp. 591-595

CrossRefView Record in ScopusGoogle Scholar

[137]

M.W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki, M. RathAntitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24

Int J Urol, 13 (2006), pp. 415-419

CrossRefView Record in ScopusGoogle Scholar

[138]

Y.J. Li, S.L. Wu, S.M. Lu, F. Chen, Y. Guo, S.M. Gan, et al.(-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-kappaB p65 inactivation

Tumour Biol, 36 (2015), pp. 2747-2761

CrossRefView Record in ScopusGoogle Scholar

[139]

I.A. Siddiqui, H. MukhtarNanochemoprevention by bioactive food components: a perspective

Pharm Res, 27 (2010), pp. 1054-1060

CrossRefView Record in ScopusGoogle Scholar

[140]

I.A. Siddiqui, V.M. Adhami, J.C. Chamcheu, H. MukhtarImpact of nanotechnology in cancer: emphasis on nanochemoprevention

Int J Nanomedicine, 7 (2012), pp. 591-605

View Record in ScopusGoogle Scholar

[141]

S. Narayanan, U. Mony, D.K. Vijaykumar, M. Koyakutty, B. Paul-Prasanth, D. MenonSequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells

Nanomedicine, 11 (2015), pp. 1399-1406

ArticleDownload PDFView Record in ScopusGoogle Scholar

[142]

S.S. Shafiei, M. Solati-Hashjin, A. Samadikuchaksaraei, R. Kalantarinejad, M. Asadi-Eydivand, N.A. Abu Osmanpigallocatechin gallate/layered double hydroxide nanohybrids: preparation, characterization, and in vitro anti-tumor study

PLoS One, 10 (2015), p. e0136530

CrossRefGoogle Scholar

[143]

N. Khan, D.J. Bharali, V.M. Adhami, I.A. Siddiqui, H. Cui, S.M. Shabana, et al.Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model

Carcinogenesis, 35 (2014), pp. 415-423

CrossRefView Record in ScopusGoogle Scholar

[144]

I.A. Siddiqui, D.J. Bharali, M. Nihal, V.M. Adhami, N. Khan, J.C. Chamcheu, et al.Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo

Nanomedicine, 10 (2014), pp. 1619-1626

ArticleDownload PDFView Record in ScopusGoogle Scholar

[145]

L. Ray, P. Kumar, K.C. GuptaThe activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate

Biomaterials, 34 (2013), pp. 3064-3076

ArticleDownload PDFView Record in ScopusGoogle Scholar

[146]

E. Ranzato, V. Magnelli, S. Martinotti, Z. Waheed, S.M. Cain, T.P. Snutch, et al.Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels

Cell Calcium, 56 (2014), pp. 285-295

ArticleDownload PDFView Record in ScopusGoogle Scholar

[147]

S. Gupta, N. Ahmad, R.R. Mohan, M.M. Husain, H. MukhtarProstate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase

Cancer Res, 59 (1999), pp. 2115-2120

View Record in ScopusGoogle Scholar

[148]

H. Fu, J. He, F. Mei, Q. Zhang, Y. Hara, S. Ryota, et al.Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E)

Cancer Prev Res (Phila), 2 (2009), pp. 531-537

CrossRefView Record in ScopusGoogle Scholar

[149]

J. Kim, X. Zhang, K.M. Rieger-Christ, I.C. Summerhayes, D.E. Wazer, K.E. Paulson, et al.Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1

J Biol Chem, 281 (2006), pp. 10865-10875

View Record in ScopusGoogle Scholar

[150]

S.M. Meeran, S.N. Patel, T.H. Chan, T.O. TollefsbolA novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells

Cancer Prev Res (Phila), 4 (2011), pp. 1243-1254

CrossRefView Record in ScopusGoogle Scholar

[151]

L. Moreira, I. Araujo, T. Costa, A. Correia-Branco, A. Faria, et al.Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism

Exp Cell Res, 319 (2013), pp. 1784-1795

ArticleDownload PDFView Record in ScopusGoogle Scholar

[152]

T.G. Shutava, S.S. Balkundi, P. Vangala, J.J. Steffan, R.L. Bigelow, J.A. Cardelli, et al.Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols

ACS Nano, 3 (2009), pp. 1877-1885

CrossRefView Record in ScopusGoogle Scholar

[153]

S.H. Tu, C.Y. Ku, C.T. Ho, C.S. Chen, C.S. Huang, C.H. Lee, et al.Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells

Mol Nutr Food Res, 55 (2011), pp. 455-466

CrossRefView Record in ScopusGoogle Scholar

[154]

F. De Amicis, A. Russo, P. Avena, M. Santoro, A. Vivacqua, D. Bonofiglio, et al.In vitro mechanism for downregulation of ER-alpha expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells

Mol Nutr Food Res, 57 (2013), pp. 840-853

CrossRefView Record in ScopusGoogle Scholar

[155]

C. Braicu, C.D. Gherman, A. Irimie, I. Berindan-NeagoeEpigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells

J Nanosci Nanotechnol, 13 (2013), pp. 632-637

CrossRefView Record in ScopusGoogle Scholar

[156]

S. Pianetti, S. Guo, K.T. Kavanagh, G.E. SonensheinGreen tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells

Cancer Res, 62 (2002), pp. 652-655

View Record in ScopusGoogle Scholar

[157]

J.Y. Jang, J.K. Lee, Y.K. Jeon, C.W. KimExosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization

BMC Cancer, 13 (2013), p. 421

View Record in ScopusGoogle Scholar

[158]

X. Pan, B. Zhao, Z. Song, S. Han, M. WangEstrogen receptor-alpha36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells

J Pharmacol Sci, 130 (2016), pp. 85-93

ArticleDownload PDFView Record in ScopusGoogle Scholar

[159]

L. Jin, C. Li, Y. Xu, L. Wang, J. Liu, D. Wang, et al.Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells

Oncol Rep, 29 (2013), pp. 1983-1990

CrossRefView Record in ScopusGoogle Scholar

[160]

K.C. Kim, C. LeeReversal of Cisplatin resistance by epigallocatechin gallate is mediated by downregulation of axl and tyro 3 expression in human lung cancer cells

Korean J Physiol Pharmacol, 18 (2014), pp. 61-66

CrossRefView Record in ScopusGoogle Scholar

[161]

J.I. Sonoda, R. Ikeda, Y. Baba, K. Narumi, A. Kawachi, E. Tomishige, et al.Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression

Exp Ther Med, 8 (2014), pp. 59-63

CrossRefView Record in ScopusGoogle Scholar

[162]

H. Wang, S. Bian, C.S. YangGreen tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha

Carcinogenesis, 32 (2011), pp. 1881-1889

CrossRefView Record in ScopusGoogle Scholar

[163]

G.X. Li, Y.K. Chen, Z. Hou, H. Xiao, H. Jin, G. Lu, et al.Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro

Carcinogenesis, 31 (2010), pp. 902-910

CrossRefView Record in ScopusGoogle Scholar

[164]

D. Sadava, E. Whitlock, S.E. KaneThe green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells

Biochem Biophys Res Commun, 360 (2007), pp. 233-237

ArticleDownload PDFView Record in ScopusGoogle Scholar

[165]

Y. Li, T. Zhang, Y. Jiang, H.F. Lee, S.J. Schwartz, D. Sun(-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2

Mol Pharm, 6 (2009), pp. 1152-1159

CrossRefView Record in ScopusGoogle Scholar

[166]

S.D. Rao, K. PagidasEpigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells

Anticancer Res, 30 (2010), pp. 2519-2523

View Record in ScopusGoogle Scholar

[167]

C. Yan, J. Yang, L. Shen, X. ChenInhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression

Arch Gynecol Obstet, 285 (2012), pp. 459-467

CrossRefView Record in ScopusGoogle Scholar

[168]

C.W. Cheng, P.C. Shieh, Y.C. Lin, Y.J. Chen, Y.H. Lin, D.H. Kuo, et al.Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells

J Agric Food Chem, 58 (2010), pp. 887-894

CrossRefView Record in ScopusGoogle Scholar

[169]

A.I. Irimie, C. Braicu, O. Zanoaga, V. Pileczki, C. Gherman, I. Berindan-Neagoe, et al.Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells

Onco Targets Ther, 8 (2015), pp. 461-470

View Record in ScopusGoogle Scholar

[170]

C.H. Lin, L.K. Chao, P.H. Hung, Y.J. ChenEGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation

Int J Clin Exp Pathol, 7 (2014), pp. 2372-2381

View Record in ScopusGoogle Scholar

[171]

J. Ma, M. Shi, G. Li, N. Wang, J. Wei, T. Wang, et al.Regulation of Id1 expression by epigallocatechin3gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells

Int J Oncol, 43 (2013), pp. 1052-1058

CrossRefView Record in ScopusGoogle Scholar

[172]

T. Tanaka, T. Ishii, D. Mizuno, T. Mori, R. Yamaji, Y. Nakamura, et al.(-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68

Free Radic Biol Med, 50 (2011), pp. 1324-1335

ArticleDownload PDFView Record in ScopusGoogle Scholar

[173]

Y. Zhang, N.D. Yang, F. Zhou, T. Shen, T. Duan, J. Zhou, et al.(-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization

PLoS One, 7 (2012), p. e46749

CrossRefGoogle Scholar

[174]

G.Y. Wubetu, M. Shimada, Y. Morine, T. Ikemoto, D. Ishikawa, S. Iwahashi, et al.Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation

J Gastroenterol Hepatol, 31 (2016), pp. 256-264

CrossRefView Record in ScopusGoogle Scholar

[175]

D.S. Albrecht, E.A. Clubbs, M. Ferruzzi, J.A. BomserEpigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation

Chem Biol Interact, 171 (2008), pp. 89-95

ArticleDownload PDFView Record in ScopusGoogle Scholar

[176]

R. Shukla, N. Chanda, A. Zambre, A. Upendran, K. Katti, R.R. Kulkarni, et al.Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer

Proc Natl Acad Sci U S A, 109 (2012), pp. 12426-12431

CrossRefView Record in ScopusGoogle Scholar

[177]

S.I. Wang, H. MukhtarGene expression profile in human prostate LNCaP cancer cells by (-) epigallocatechin-3-gallate

Cancer Lett, 182 (2002), pp. 43-51

ArticleDownload PDFView Record in ScopusGoogle Scholar

[178]

C.P. Chuu, R.Y. Chen, J.M. Kokontis, R.A. Hiipakka, S. LiaoSuppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells

Cancer Lett, 275 (2009), pp. 86-92

ArticleDownload PDFView Record in ScopusGoogle Scholar

[179]

C.E. Harper, B.B. Patel, J. Wang, I.A. Eltoum, C.A. LamartiniereEpigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action

Prostate, 67 (2007), pp. 1576-1589

CrossRefView Record in ScopusGoogle Scholar

[180]

J. Li, S. Wu, C. Wu, L. Qiu, G. Zhu, C. Cui, et al.Versatile surface engineering of porous nanomaterials with bioinspired polyphenol coatings for targeted and controlled drug delivery

Nanoscale, 8 (2016), pp. 8600-8606

View Record in ScopusGoogle Scholar

[181]

N.Y. Min, J.H. Kim, J.H. Choi, W. Liang, Y.J. Ko, S. Rhee, et al.Selective death of cancer cells by preferential induction of reactive oxygen species in response to (-)-epigallocatechin-3-gallate

Biochem Biophys Res Commun, 421 (2012), pp. 91-97

ArticleDownload PDFView Record in ScopusGoogle Scholar

[182]

H. Jin, W. Gong, C. Zhang, S. WangEpigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling

Onco Targets Ther, 6 (2013), pp. 145-153

View Record in ScopusGoogle Scholar

[183]

D. Umeda, S. Yano, K. Yamada, H. TachibanaInvolvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells

Biochem Biophys Res Commun, 371 (2008), pp. 172-176

ArticleDownload PDFView Record in ScopusGoogle Scholar

[184]

B. Hu, Y. Ting, X. Yang, W. Tang, X. Zeng, Q. HuangNanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

Chem Commun (Camb), 48 (2012), pp. 2421-2423

CrossRefView Record in ScopusGoogle Scholar

[185]

J.H. Yuan, Y.Q. Li, X.Y. YangInhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice

Pharmacology, 80 (2007), pp. 269-278

CrossRefView Record in ScopusGoogle Scholar

[186]

K. Ogawa, T. Hara, M. Shimizu, J. Nagano, T. Ohno, M. Hoshi, et al.(-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells

Oncol Lett, 4 (2012), pp. 546-550

CrossRefView Record in ScopusGoogle Scholar

[187]

A. Alotaibi, P. Bhatnagar, M. Najafzadeh, K.C. Gupta, D. AndersonTea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs

Nanomedicine (Lond), 8 (2013), pp. 389-401

CrossRefView Record in ScopusGoogle Scholar

[188]

T. Singh, S.K. KatiyarGreen tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting beta-catenin signaling

Toxicol Appl Pharmacol, 273 (2013), pp. 418-424

ArticleDownload PDFView Record in ScopusGoogle Scholar[189]

S. Balasubramanian, G. Adhikary, R.L. EckertThe Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival

Carcinogenesis, 31 (2010), pp. 496-503

CrossRefView Record in ScopusGoogle Scholar

[190]

H. Mukhtar, M.S. Matsui, D. Maes, K. Marenus, K. Tubesing, C.A. ElmetsPrevention by green tea polyphenols against ultraviolet-induced erythema in humans

J Invest Dermatol, 106 (1996), p. 243

Google Scholar

© 2017 Mansoura University. Production and hosting by Elsevier B.V.

https://www.sciencedirect.com/science/article/pii/S2314808X1730533X